Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Scott Integrated Pain Management Offers Innovative Ketamine Treatment for Complex Regional Pain Syndrome (CRPS)

Philadelphia, PA (Newsworthy.ai) Saturday Jan 27, 2024 @ 7:00 AM Eastern —

Scott Integrated Pain Management, a premier healthcare provider specializing in chronic pain management, is thrilled to announce the introduction of Ketamine treatment for patients grappling with Complex Regional Pain Syndrome (CRPS). This groundbreaking therapy aims to bring relief to individuals experiencing severe and debilitating pain.

CRPS, characterized by intense and continuous pain that worsens over time, often leaves patients without adequate relief from traditional treatments. This has fueled the need for alternative options that can help individuals regain control of their lives. Ketamine, originally developed as a dissociative anesthetic for surgery, has shown great promise in significantly reducing pain and improving the quality of life for CRPS patients.

Recent research has highlighted Ketamine's effectiveness in managing chronic pain conditions, including CRPS. By modulating pain receptors in the brain, Ketamine disrupts the cycle of pain signaling, providing respite to individuals burdened by constant discomfort.

Patients undergoing Ketamine therapy at Scott Integrated Pain Management can anticipate a comprehensive evaluation to determine their eligibility. Treatment plans are tailored to individual requirements, ensuring the most effective and safe outcomes. Scott Integrated Pain Management accepts various insurance plans, including Medicare, United Healthcare, Independence Blue Cross Blue Shield, Cigna, and Highmark BlueShield, making this groundbreaking treatment accessible to a wide range of patients.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Scott Integrated Pain Management Offers Innovative Ketamine Treatment for Complex Regional Pain Syndrome (CRPS).

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.